Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of tolvaptan in transurethral resection of prostate
jRCT1091220168Completed
- Sponsor
- Osaka Medical and Pharmaceutical University
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tolvaptan in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Osaka Medical and Pharmaceutical University. Primary endpoint: Change of serum sodium and occurrence of TUR syndrome. Started Mar 2014; status: completed.
02
Drugs
tolvaptan
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on jRCT1091220168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220168.